Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, which is the leading cancer killer in the world. Despite the recent advances in its diagnosis and therapy, the prognosis of NSCLC patients remains very poor, mainly due to the development of drug resistance and metastasis. Bo...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Jun, Xue, Ying, Long, Meijun, Zhang, Ge, Zhang, Junhang, Su, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503609/
https://www.ncbi.nlm.nih.gov/pubmed/28424406
http://dx.doi.org/10.18632/oncotarget.16837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503609/
https://www.ncbi.nlm.nih.gov/pubmed/28424406
http://dx.doi.org/10.18632/oncotarget.16837

Ejemplares similares